A new phase of trials to test two promising HIV vaccines began last week in London and Oxford. The vaccines—one made of naked DNA, the other a weakened pox virus—contain genes from a common strain of HIV in Africa, and should provoke an immune response that fends off the virus itself. Volunteers are receiving different combinations of the vaccines or a placebo. Teams at Imperial College in London and the Medical Research Council’s Human Immunology Unit in Oxford hope to recruit 120 volunteers aged 18 to 60, who must be HIV-negative.
To continue reading, today with our introductory offers
Advertisement
More from New ÒÁÈ˾þÃ
Explore the latest news, articles and features
Life
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
News
Environment
First test of CO2 removal with green sand finds no harm to marine life
News
Space
SpaceX is about to launch tallest and most powerful rocket in history
News
Environment
Cleaning up air pollution could weaken vital AMOC ocean current
News
Popular articles
Trending New ÒÁÈ˾þà articles
1
A new tectonic plate boundary could be forming in southern Africa
2
First test of CO2 removal with green sand finds no harm to marine life
3
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
4
Why autism pioneer Uta Frith wants to dismantle the spectrum
5
CAR T-cell therapy bolstered by stiffening up cancer cells first
6
Where do you think your ‘self’ is? Your answer is revealing
7
SpaceX is about to launch tallest and most powerful rocket in history
8
Where did the laws of physics come from? I think I've found the answer
9
PCOS has been officially renamed PMOS, and it’s a momentous move
10
New ÒÁÈ˾þà recommends visiting the blooming corpse flower at Kew
